INTENSIFIED CHEMOTHERAPY WITHOUT SCT IN INFANT ALL: RESULTS FROM COG P9407 (Cohort 3)

BACKGROUND: Infants with acute lymphoblastic leukemia (ALL) present with aggressive disease and a poor prognosis. Early relapse within 6–9 months of diagnosis is common. Approximately 75% of infants have MLL-rearranged (MLL-R) ALL with event free survival (EFS) ranging from 20–30%. Children’s Oncolo...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Pediatr Blood Cancer
Hoofdauteurs: Dreyer, ZoAnn E., Hilden, Joanne M., Jones, Tamekia L., Devidas, Meenakshi, Winick, Naomi J., Willman, Cheryl L., Harvey, Richard C., Chen, I-Ming, Behm, Fred G., Pullen, Jeanette, Wood, Brent L., Carroll, Andrew J., Heerema, Nyla A., Felix, Carolyn A., Robinson, Blaine, Reaman, Gregory H., Salzer, Wanda L., Hunger, Stephen P., Carroll, William L., Camitta, Bruce M.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2014
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5145261/
https://ncbi.nlm.nih.gov/pubmed/25399948
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.25322
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items